Skip to main content

Advertisement

SpringerLink
Log in

Mind the potential metabolic consequences of migraine prophylaxis: a case study

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Belcastro V, D’Egidio C, Striano P et al (2013) Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Res 107:1–8

    Article  CAS  Google Scholar 

  2. Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S (2004) Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. J Child Neurol 19:135–141

    Article  Google Scholar 

  3. Lee MH, Kim M, Lee BH et al (2008) Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver. Toxicol Appl Pharmacol 226:271–284

    Article  CAS  Google Scholar 

  4. El-Khatib F, Rauchenzauner M, Lechleitner M et al (2007) Valproate, weight gain and carbohydrate craving: a gender study. Seizure 16:226–232

    Article  Google Scholar 

  5. Stephen LJ, Kwan P, Shapiro D et al (2001) Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 42:1002–1006

    Article  CAS  Google Scholar 

Download references

Funding

PS and BVDS are funded by a research Grant of the Research Foundation—Flanders (FWO), Grant Numbers: 1S82221N/1802720 N.

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Hepatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    Pieter Sinonquel

  2. Department of Translational Research in Gastrointestinal Diseases (TARGID), KU Leuven, Herestraat 49, 3000, Leuven, Belgium

    Pieter Sinonquel

  3. Department of Endocrinology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    Sébastien Verdickt, Roman Vangoitsenhoven & Bart Van der Schueren

  4. Clinical Department of Laboratory Medicine, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    Pieter Vermeersch

  5. Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Herestraat, 49, 3000, Leuven, Belgium

    Roman Vangoitsenhoven & Bart Van der Schueren

Authors
  1. Pieter Sinonquel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sébastien Verdickt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pieter Vermeersch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roman Vangoitsenhoven
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bart Van der Schueren
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PS, BVDS are responsible for the concept of this paper. PS wrote the manuscript and adjusted the figure and made the tables. All other authors provided valuable clinical follow-up and treatment as well as their feedback, suggestions, validation of the procedures on the work floor and corrections to improve the quality of the manuscript. Final approval: all authors.

Corresponding author

Correspondence to Pieter Sinonquel.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sinonquel, P., Verdickt, S., Vermeersch, P. et al. Mind the potential metabolic consequences of migraine prophylaxis: a case study. Acta Neurol Belg 122, 1361–1363 (2022). https://doi.org/10.1007/s13760-021-01776-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-021-01776-1

Search

Navigation